secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0001213900-23-017895
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences issues convertible note to director for $1M and warrants for services
--------------------------------------------------------------------------------

- Director loaned $1M via convertible note due demand after 1 yr, 10% interest, convertible at $0.50/share into 2M shares.
- Two individuals received warrants for 250K shares each at $0.50/share for consulting services.
- Consulting firm received 5-yr warrant for 500K shares at $0.47/share for services.
- Total shares underlying instruments represent ~6% of pre-issuance common stock.
- Securities issued without registration under Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390023017895/0001213900-23-017895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390023017895/ea174679-8k_emmauslife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-017895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer